Chemokine (CCR) and fractalkine (CX3CR) receptors and end stage renal disease

Inflammation Research

Volumn 60, Issue 4, 2011, Pages 399-407

  Borkar, Minal ^b   Tripathi, Gaurav ^a   Sharma, Raj Kumar ^b   Sankhwar, Satya Narayan ^a   Agrawal, Suraksha ^b  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

CCR; Chemokine receptors; ESRD; Single nucleotide polymorphisms (SNPs)

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1;

ADULT; ARTICLE; CHROMOSOME 3P; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; INFLAMMATION; KIDNEY FAILURE; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; POLYMORPHISM, GENETIC; RECEPTORS, CCR5; RECEPTORS, CYTOKINE; RECEPTORS, HIV;

EID: 79955939122     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0284-3     Document Type: Article

References (28)

1. Bursill CA, Channon KM, Greaves DR. The role of chemokines in atherosclerosis: Recent evidence from experimental models and population genetics. Curr Opin Lipidol. 2004;15:145-9. (Pubitemid 38453402)
2. Zernecke A, Shagdarsuren E, Weber C. Chemokines in atherosclerosis: An update. Arterioscler Thromb Vasc Biol. 2008;28:1897-908.
3. Raport CJ, Gosling J, Schweickart VL, Gray PW, Charo IF. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP- 1beta, and MIP-1alpha. J Biol Chem. 1996;271:17161-6. (Pubitemid 26244268)
4. Simeoni E, Vassalli G, Seydoux C, et al. CCR5, RANTES and CX3CR1 polymorphisms: possible genetic links with acute heart rejection. Transplantation. 2005;80:1309-16.
5. Schröppel B, Fischereder M, Lin M, et al. Analysis of gene polymorphisms in the regulatory region of MCP-1, RANTES, and CC5 in liver transplant recipients. J Clin Immunol. 2002;22:381-5. (Pubitemid 35305888)
6. Hoffmann S, Park J, Jacobson LM, et al. Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. Kidney Int. 2004;66:1686-93. (Pubitemid 39298406)
7. Yigit B, Bozkurt N, Berber I, et al. Analysis of CC chemokine receptor 5 and 2 polymorphisms and renal transplant survival. Cell Biochem Funct. 2007;25:423-6. (Pubitemid 47066719)
8. Abdi R, Tran TB, Sahagun-Ruiz A, Murphy PM, Brenner BM, Milford EL, Mcdermott DH. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol. 2002;13:754-8. (Pubitemid 34183942)
9. Schlondorff D, Nelson PJ, Lucknow B, Banas B. Chemokines and renal disease. Kidney Int. 1997;51:610-21. (Pubitemid 27157943)
10. Fischereder M, Luckow B, Hocher B, et al. CC chemokine receptor 5 and renal-transplant survival. Lancet. 2001;23: 1758-61. (Pubitemid 32524207)
11. Takacova M, Nogova P, Habekova M, et al. Prevalence of a 32 bp deletion in the gene for human immunodeficiency virus 1 co-receptor ccr5 in Slovak population. Acta Virol. 2008;52:261-4.
12. Thio CL, Astemborski J, Thomas R, et al. Interaction between RANTES promoter variant and CCR5d32 favors recovery from hepatitis B. J Immunol. 2008;181:7944-7.
13. Wang F, Xiul MH, Zhou DF, et al. The CCR5 32-bp deletion allele is rare in a Chinese population. Schizophr Res. 2008;101:341-3.
14. Horuk R. Chemokine receptors. Cytokine Growth Factor Rev. 2001;12:313-35. (Pubitemid 32851745)
15. Hancock WW. Chemokines and transplant immunobiology. J Am Soc Nephrol. 2002;13:821-4. (Pubitemid 34183952)
16. Faure S, Meyer L, Costagliola D, et al. Rapid progression to AIDS among HIV+ individuals with an allelic variants of the CX3CR1 chemokine receptor. Science. 2000;287:2274-7. (Pubitemid 30177034)
17. Moatti D, Faure S, Fumeron F, Amara Mel-W, Seknadji P, McDermott DH, Debre P, Aumont MC, Murphy PM, de Prost D, Combadiere C. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood. 2001;97:1925-8. (Pubitemid 32239068)
18. Balistreri CR, Caruso C, Grimaldi MP, Listi F, Vasto S, Orlando V, Campagna AM, Lio D, Candore G. CCR5 receptor: Biologic and genetic implications in age-related diseases. Ann N Y Acad Sci. 2007;1100:162-72. (Pubitemid 47092648)
19. Pai JK, Kraft P, Cannuscio CC, Manson JE, Rexrode KM, Albert CM, Hunter D, Rimm EB. Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of coronary heart disease among US women. Atherosclerosis. 2006;186:132-9.
20. Manchanda PK, Singh R, Mittal RD. Cytokine (IL-10-1082 and - 819) and chemokine receptor (CCR2 and CCR5) gene polymorphism in North Indian patients with end-stage renal disease. DNA Cell Biol. 2009;28:177-83.
21. Muntinghe FL, Verduijn M, Zuurman MW, Grootendorst DC, Carrero JJ, Qureshi AR, Luttropp K, Nordfors L, Lindholm B, Brandenburg V, Schalling M, Stenvinkel P, Boeschoten EW, Krediet RT, Navis G, Dekker FW. CCR5 deletion protects against inflammation-associated mortality in dialysis patients. J Am Soc Nephrol. 2009;20:1641-9.
22. Furuta T, Salto T, Ootaka T, Soma J, Obara K, Abe K, Yoshinaga K. The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis. 1993;21:480-5. (Pubitemid 23160508)
23. Cha RH, Yang SH, Kim HS, Kim SM, Park MH, Ha J, Kim YS. Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5. Nephrol Dial Transplant. 2009;24:2919-25.
24. Böger CA, Fischereder M, Deinzer M, Aslanidis C, Schmitz G, Stubanus M, Banas B, Krüger B, Riegger GA, Krämer BK. RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients. Atherosclerosis. 2005;183:121-9. (Pubitemid 41416830)
25. Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res. 2009;28:1-18.
26. Lu Y, Nerurkar VR, Dashwood WM, Woodward CL, Ablan S, Shikuma CM, Grandinetti A, Chang H, Nguyen HT, Wu Z, Yamamura Y, Boto WO, Merriwether A, Kurata T, Detels R, Yanagihara R. Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: absence of mutation among Asians and Pacific Islanders. Int J Infect Dis. 1999;3:186-91.
27. DeVries ME, Cao H, Wang J, Xu L, Kelvin AA, Ran L, Chau LA, Madrenas J, Hegele RA, Kelvin DJ. Genomic organization and evolution of the CX3CR1/CCR8 chemokine receptor locus. J Biol Chem. 2003;278:11985-94. (Pubitemid 36800173)
28. Rathore A, Chatterjee A, Sivarama P, Yamamoto N, Singhal PK, Dhole TN. Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians. AIDS Res Hum Retro-viruses. 2009;25:1149-56.